Recent advances in the study of dendrimers-based drug delivery systems

Yaoxue Xuebao

Volumn 42, Issue 9, 2007, Pages 924-929

  Zheng, Chang ^a   Qiao, Ming Xi ^a   Yan, Lu ^a   Hu, Hai Yang ^a   Chen, Da Wei ^a  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Dendrimer; Drug carrier; Gene carrier

Indexed keywords

DENDRIMER; PAMAM STARBURST; POLYAMINE;

ARTICLE; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG DESIGN;

DENDRIMERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; POLYAMINES;

EID: 42149114546     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Tomalia DA, Baker H, Dewald J, et al. A new class of polymers starbust-dendrimtic macro-molecules [J]. Polym J, 1985,17:117-132.
2. Newkome GR, Moorefield CN, Baker GR, et al. Unimolecular micelles [J]. Angew Chem Int, 1991,30: 1178-1180.
3. Stevelmans S, van Hest JCM, Jansen J, et al. Synthesis, characterization, and guest-host properties of inverted unimoleculardendritic micelles [J]. J Am Chem Soc, 1996,118:7398-7399.
4. Hawker CJ, Wooley KL, Fre'chet JMJ. Unimolecularmicelles and globular amphiphiles; dendritic macromolecules as novel recyclable solubilization agents [J]. J Chem Soc, 1993,1:1287-1297.
5. Huang F. Study on the synthesis and surface activity of PAMAM dendrimer [D]. Beijing: Beijing University of Chemical Technology, 2004.
6. Svenson S, Tomalia DA. Dendrimers in biomedical applications-reflections on the field [J]. Adv Drug Deliv Rev, 2005,57:2106-2129.
7. Ma M, Cheng Y, Xu Z, et al. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti-bacterial drugs using sulfamethoxazole (SMZ) as a model drug [J]. Eur J Med Chem, 2007,42:93-98.
8. Milhem OM, Myles C, McKeown NB, et al. Polyamidoamine starburst dendrimers as solubility enhancers [J]. Int J Pharm, 2000,197:239-241.
9. Malik N, Evagorou EG, Duncan R. Dendrimer-platinate: a novel approach to cancer chemotherapy [J]. Anti-cancer Drugs, 1999,10:767-776.
10. De Jesu' s Padilla OL, Ihre HR, Gagne L, et al. Polyester dendritic systems for drug delivery applications: in vitro and in vivo evaluation [J]. Bioconjug Chem, 2002,13:453-461.
11. Greenfield RS, Kaneko T, Daues A, et al. In vitro evaluation of adriamycin immuno-conjugates synthesized using an acid-sensitive hydrazone linker [J]. Cancer Res, 1990,50:6600-6607.
12. Devarakonda B, Hill RA, Liebenberg W, et al. Comparison of the aqueous solubilization of practically insoluble niclosamide by polyamidoamine (PAMAM) dendrimers and cyclodextrins [J]. Int J Pharm, 2005, 304:193-209.
13. Pan G, Lemmouchi Y, Akala EO, et al, Studies on PEGylated and drug-loaded PAMAM dendrimers [J]. J Bioact Compat Polym, 2005,20:113-128.
14. Ye L, Jing XZ, Yang H, et al, Complex and in vitro release of methotrexate-PAMAM dendrimer [J]. Chem J Chin Univ, 2005,26:353-355.
15. Ye L, Yang H, He ML, et al. Investigation of PAMAM dendrimer MTX complex: formation and in vitro release [J]. Acta Polym Sin, 2006,1:32-36.
16. Kolhe P, Khandare J, Pillai O, et al. Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload [J]. Biomaterials, 2006,27:660-669.
17. Najlah M, Freeman S, Attwood D, et al. Synthesis, characterization and stability of dendrimer prodrugs [J]. Int J Pharm, 2006,308:175-182.
18. Patri AK, Kukowska-Latallo JF, Baker JR. Targeted drug delivery with dendrimers; Comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex [J]. Adv Drug Deliv Rev, 2005, 57:2203-2214.
19. Bhadra D, Bhadra S, Jain S, et al. A PEGylated dendritic nanoparticulate carrier of fluorouracil [J]. Int J Pharm, 2003,257:111-124.
20. Okuda T, Kawakami S, Akimoto N, et al. PEGylated lysine dendrimers for tumor-selective targeting afterintravenous injection in tumor-bearing mice [J]. J Control Release, 2006,116:330-336.
21. Chandrasekara D, Sistlaa R, Ahmadb FJ, et al. The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats [J]. Biomaterials, 2007,28:504-512.
22. Choi Y, Thomas T, Kotlyar A. Synthesis and functional evaluation of DNA-assembled polyamidoamine dendrimer clusters for cancer cell-specific targeting [J]. Chem Biol, 2005,12:35-43.
23. Sampathkumar SG, Yarema KJ. Targeting cancer cells with dendrimers [J]. Chem Biol, 2005,12:5-13.
24. Huang W, Cui GH, He JF. Preliminary study of chitosan nanoparticles used as gene delivery carriers [J]. Acta Pharm Sin, 2002,37:981-985.
25. Kang R, Cao LZ. The current research status of the application of nanometer carrier polyamidoamine dendrimers in cancer therapy [J]. Foreign Med Sci (Pediatr). 2004,31:96-98.
26. Li N, Zhang YH, Xiong XL. Applications of dendrimers in pharmaceuticals [J]. Chin J Pharm, 2006,37:275-279.
27. Choi JS, Nam K, Park JY, et al. Enhanced transfection efficiency of PAMAM dendrimer by surface modification with L-arginine [J]. J Control Release, 2004,99:445-456.
28. Yamagata M, Kawano T, Shiba K, et al. Structural advantage of dendritic poly (L-lysine) for gene delivery into cells [J]. Bioorgan Med Chem, 2007,15:526-532.
29. Chen HT, Neerman MF, Parrish AR, et al. Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery [J]. J Am Chem Soc, 2004,126:10044-10048.
30. Lee H, Lim YB, Choi JS, et al. Polyplexes assembled with internally quaternized PAMAM-OH dendrimer and plasmid DNA have a neutral surface and gene delivery potency [J]. Bioconjug Chem, 2003,14:1214-1221.
31. Jevprasesphant R, Penny J, Jalal R, et al. The influence of surface modification on the cytotoxicity of PAMAM dendrimers [J]. Int J Pharm, 2003,252:263-266.